Transcriptomics

Dataset Information

0

Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies I


ABSTRACT: IFNγ neutralization by the clinically approved monoclonal antibody emapalumab mitigates severe toxicity related to CAR-T therapy Emapalumab does not impair CAR.CD19 T-cell activation signaling

ORGANISM(S): Homo sapiens

PROVIDER: GSE228921 | GEO | 2023/05/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-05-04 | GSE228922 | GEO
2023-05-04 | GSE228924 | GEO
2022-03-07 | PXD030580 | Pride
2023-05-06 | E-MTAB-12624 | biostudies-arrayexpress
2022-02-24 | GSE154040 | GEO
2023-05-06 | E-MTAB-12625 | biostudies-arrayexpress
2024-08-20 | GSE222222 | GEO
2024-03-09 | GSE260972 | GEO
2023-08-08 | E-MTAB-12195 | biostudies-arrayexpress
2023-08-22 | E-MTAB-12196 | biostudies-arrayexpress